首页 > 抗体蛋白 > 抗体
Purified anti-mouse CD69 Antibody
产品名称:
Purified anti-mouse CD69 Antibody
产品类别:
抗体
产品编号:
104502
产品应用:
104502
[价格]
规格 价格 库存
500µg ¥ 3036 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse dendritic epidermal T cell line Y245
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, IP - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

The H1.2F3 antibody has been reported to augment T cell activation. Additional reported applications (for the relevant formats) include: in vitro T cell and NK cell activation1-3, immunohistochemistry4,5, and immunoprecipitation1.

This antibody has been characterized in the literature as containing a lambda (?) light chain.

Application References

(PubMed link indicates BioLegend citation)
  1. Yokoyama WM, et al. 1988. J. Immunol. 141:369. (IP)
  2. Sobel ES, et al. 1993. J. Immunol. 150:673.
  3. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  4. Zhou X, et al. 2005. J. Biol. Chem. 280:31240. (IHC)
  5. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
  6. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  7. Lee JW, et al. 2006. Nature Immunol. 8:181.
  8. Epardaud M, et al. 2008. Cancer Res. 15:2972. PubMed
  9. Jordan JM, et al. 2008. 76:3717. PubMed
  10. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  11. Ishikawa C, et al. 2013. Biochim Biophys Acta. 167:99. PubMed
Product Citations
  1. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  2. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  3. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  4. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  5. Guo R, et al. 2020. Cell Res. 30:21. PubMed
  6. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  7. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  8. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  9. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  10. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  11. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  12. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  13. Kroczek AL, et al. 2019. Front Immunol. 9:2806. PubMed
  14. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  15. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  16. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  17. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  18. Kiripolsky J, et al. 2021. J Autoimmun. 118:102608. PubMed
  19. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  20. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  21. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  22. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  23. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  24. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  25. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  26. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  27. Ishikawa C, et al. 2013. Biochim Biophys Acta. 167:99. PubMed
  28. Park GY, et al. 2020. Immune Netw. e43:20. PubMed
  29. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  30. Sun Y, et al. 2020. J Immunol. 205:3358. PubMed
  31. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  32. Kenna T, et al. 2008. Blood. 111:2091. PubMed
  33. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  34. Karmaus P, et al. 2011. J Leukoc Biol. 90:983. PubMed
  35. Roy S, et al. 2018. Cancer Res. 78:5600. PubMed
  36. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  37. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  38. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  39. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  40. Scutts SR, et al. 2018. Cell Rep. 25:1953. PubMed
  41. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  42. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  43. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  44. Richards KA, et al. 2018. Front Immunol. 0.829861111. PubMed
  45. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  46. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  47. Rios–Doria J, et al. 2017. Cancer Res. 77:2686. PubMed
  48. Jordan J, et al. 2008. Infect Immun. 76:3717. PubMed
  49. Epardaud M, et al. 2008. Cancer Res. 68:2972. PubMed
  50. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  51. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
RRID
AB_313105 (BioLegend Cat. No. 104502)

Antigen Details

Structure
C-type lectin, 27/33 kD
Distribution

Activated T cells and B cells, NK cells, granulocytes, thymocytes, platelets

Function
Lymphocyte activation
Cell Type
B cells, Granulocytes, NK cells, Platelets, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Testi R, et al. 1994. Immunol. Today 15:479.
3. Moretta A, et al. 1991. J. Exp. Med. 174:1393.
4. Yokoyama WM, et al. 1988. J. Immunol. 141:369.

Gene ID
12515 View all products for this Gene ID
UniProt
View information about CD69 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线